Exploring the Potential of Mesenchymal Stem Cell-Based Therapy in Mouse Models of Vascular Cognitive Impairment

• Published in: International journal of molecular sciences Vol. 21; no. 15; p. 5524
• Main Authors: Lee, Na Kyung, Kim, Hyeongseop, Chang, Jong Wook, Jang, Hyemin, Kim, Hunnyun, Yang, Jehoon, Kim, Jeyun, Son, Jeong Pyo, Na, Duk L
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.08.2020; MDPI
• Subjects: Alzheimer Disease - genetics; Alzheimer Disease - therapy; Alzheimer's disease; Animal models; Animals; Carotid Stenosis - complications; Cognitive ability; Cognitive Dysfunction - etiology; Cognitive Dysfunction - physiopathology; Cognitive Dysfunction - therapy; Constrictors; Dementia; Dementia, Vascular - etiology; Dementia, Vascular - physiopathology; Dementia, Vascular - therapy; Disease; Disease Models, Animal; Disease Progression; Experiments; Health services; Heterogeneity; Humans; Immunogenicity; Impairment; Injections, Intraventricular; Kaplan-Meier Estimate; Memory; Memory, Short-Term - physiology; mesenchymal stem cell; Mesenchymal Stem Cell Transplantation - methods; Mesenchymal stem cells; Mesenchymal Stem Cells - cytology; Mice, Inbred C57BL; Mice, Transgenic; Mortality; Motor ability; Researchers; Short term memory; Spatial memory; Stem cell transplantation; Stem cells; Stenosis; Survival analysis; therapeutic; Transgenic mice; Transplantation, Heterologous; Transplants & implants; vascular cognitive impairment; therapeutic; vascular cognitive impairment; mesenchymal stem cell; Alzheimer’s disease; heterogeneity
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms21155524

Closely linked to Alzheimer's disease (AD), the pathological spectrum of vascular cognitive impairment (VCI) is known to be wide and complex. Considering that multiple instead of a single targeting approach is considered a treatment option for such complicated diseases, the multifaceted aspects of mesenchymal stem cells (MSCs) make them a suitable candidate to tackle the heterogeneity of VCI. MSCs were delivered via the intracerebroventricular (ICV) route in mice that were subjected to VCI by carotid artery stenosis. VCI was induced in C57BL6/J mice wild type (C57VCI) mice by applying a combination of ameroid constrictors and microcoils, while ameroid constrictors alone were bilaterally applied to 5xFAD (transgenic AD mouse model) mice (5xVCI). Compared to the controls (minimal essential medium (MEM)-injected C57VCI mice), changes in spatial working memory were not noted in the MSC-injected C57VCI mice, and unexpectedly, the mortality rate was higher. In contrast, compared to the MEM-injected 5xVCI mice, mortality was not observed, and the spatial working memory was also improved in MSC-injected 5xVCI mice. Disease progression of the VCI-induced mice seems to be affected by the method of carotid artery stenosis and due to this heterogeneity, various factors must be considered to maximize the therapeutic benefits exerted by MSCs. Factors, such as the optimal MSC injection time point, cell concentration, sacrifice time point, and immunogenicity of the transplanted cells, must all be adequately addressed so that MSCs can be appropriately and effectively used as a treatment option for VCI.